Insurer AXA's venture capital platform AXA Strategic Ventures has invested in BioBeats - a machine learning platform that delivers information about the wellbeing of individuals in real time.
Using existing wearables and smartphones, this cloud-based programme gathers biometric information about wellbeing and builds a unique profile on a personal dashboard regarding sleep, activity, and stress.
The software uses these insights to design a personalised coaching programme around individual wellbeing goals.
The application is currently running advanced pilot programmes in major UK healthcare companies and corporates, including with AXA PPP Healthcare.
The funding round (£1.6m) led by White Cloud Capital with the participation of IQ Capital, will be used to implement product delivery and commercialisation of its biometrics based, stress-relieving app, Hear and Now, for both the consumer and corporate wellness market, as well as the company's expansion into the US market.
David Plans, CEO and co-founder at BioBeats said: "A deep understanding of employee wellness is critical to building a great global business, and BioBeats allows companies to keep a finger on the pulse of their organisations and encourage individuals to own their wellness."
Minh Q.Tran, general partner at AXA Strategic Ventures said: "We are convinced that prevention is the best cure and that BioBeats' approach will allow our business customers to understand employee wellness and build greater, global businesses."
Adviser firm believes
Thursday 12 March
Dementia UK reaction
Alleged ‘conflict of interest’
Featuring NHS Trust